AR008474A1 - Derivado de 9-dihidroeritromicina a 6,9; 11,12-diciclocarbonato, composicion farmaceutica y preparacion bactericida que lo contienen y su uso - Google Patents
Derivado de 9-dihidroeritromicina a 6,9; 11,12-diciclocarbonato, composicion farmaceutica y preparacion bactericida que lo contienen y su usoInfo
- Publication number
- AR008474A1 AR008474A1 ARP970104338A ARP970104338A AR008474A1 AR 008474 A1 AR008474 A1 AR 008474A1 AR P970104338 A ARP970104338 A AR P970104338A AR P970104338 A ARP970104338 A AR P970104338A AR 008474 A1 AR008474 A1 AR 008474A1
- Authority
- AR
- Argentina
- Prior art keywords
- dihydroerythromycin
- derivative
- diciclocarbonato
- contain
- pharmaceutical composition
- Prior art date
Links
- 230000000844 anti-bacterial effect Effects 0.000 title 1
- 239000003899 bactericide agent Substances 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
- C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
- C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Oncology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
Abstract
Un derivado de 9-dihidroeritromicina A 6,9; 11,12-diciclocarbonato caracterizado por la formula (I).
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP25105096 | 1996-09-24 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR008474A1 true AR008474A1 (es) | 2000-01-19 |
Family
ID=17216881
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP970104338A AR008474A1 (es) | 1996-09-24 | 1997-09-22 | Derivado de 9-dihidroeritromicina a 6,9; 11,12-diciclocarbonato, composicion farmaceutica y preparacion bactericida que lo contienen y su uso |
Country Status (7)
Country | Link |
---|---|
US (1) | US5804565A (es) |
JP (1) | JP2001500895A (es) |
AR (1) | AR008474A1 (es) |
AU (1) | AU4222797A (es) |
CO (1) | CO4950559A1 (es) |
WO (1) | WO1998013373A1 (es) |
ZA (1) | ZA978546B (es) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1351608A (zh) | 1999-05-24 | 2002-05-29 | 辉瑞产品公司 | 13-甲基红霉素衍生物 |
US20020115621A1 (en) * | 2000-08-07 | 2002-08-22 | Wei-Gu Su | Macrolide antibiotics |
WO2004101592A1 (ja) * | 2003-05-19 | 2004-11-25 | Taisho Pharmaceutical Co., Ltd. | エリスロマイシンa誘導体の製造方法 |
PT1836211E (pt) | 2004-12-21 | 2010-04-08 | Pfizer Prod Inc | Macrólidos |
AR085286A1 (es) | 2011-02-21 | 2013-09-18 | Taisho Pharmaceutical Co Ltd | Derivado de macrolido sustituido en la posicion c-4 |
Family Cites Families (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4331803A (en) * | 1980-06-04 | 1982-05-25 | Taisho Pharmaceutical Co., Ltd. | Novel erythromycin compounds |
JPH0633312B2 (ja) * | 1986-05-02 | 1994-05-02 | 大正製薬株式会社 | 14−ハイドロキシエリスロマイシン誘導体およびその製造方法 |
KR960000434B1 (ko) * | 1986-12-17 | 1996-01-06 | 다이쇼 세이야꾸 가부시끼가이샤 | 에리스로마이신 a유도체 및 그의 제조 방법 |
IL114589A (en) * | 1990-11-21 | 1999-12-22 | Roussel Uclaf | Intermediates for the preparation of the history of erythromycin |
WO1992009614A1 (fr) * | 1990-11-28 | 1992-06-11 | Taisho Pharmaceutical Co., Ltd. | Derive de 6-o-methylerythromycine a |
US5523399A (en) * | 1991-12-27 | 1996-06-04 | Taisho Pharmaceutical Co., Ltd. | 5-O-desosaminylerythronolide derivatives |
FR2692579B1 (fr) * | 1992-06-19 | 1995-06-02 | Roussel Uclaf | Nouveaux dérivés de la picromycine, leur procédé de préparation et leur application comme médicaments. |
US5393743A (en) * | 1993-07-06 | 1995-02-28 | Abbott Laboratories | Erythromycin derivatives |
-
1997
- 1997-09-17 US US08/931,949 patent/US5804565A/en not_active Expired - Fee Related
- 1997-09-22 JP JP10515485A patent/JP2001500895A/ja active Pending
- 1997-09-22 AU AU42227/97A patent/AU4222797A/en not_active Abandoned
- 1997-09-22 WO PCT/JP1997/003360 patent/WO1998013373A1/en active Application Filing
- 1997-09-22 AR ARP970104338A patent/AR008474A1/es unknown
- 1997-09-23 ZA ZA9708546A patent/ZA978546B/xx unknown
- 1997-09-23 CO CO97055290A patent/CO4950559A1/es unknown
Also Published As
Publication number | Publication date |
---|---|
AU4222797A (en) | 1998-04-17 |
US5804565A (en) | 1998-09-08 |
WO1998013373A1 (en) | 1998-04-02 |
CO4950559A1 (es) | 2000-09-01 |
ZA978546B (en) | 1998-04-01 |
JP2001500895A (ja) | 2001-01-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2195970T3 (es) | L-ribavirina y usos de la misma. | |
CL2004001102A1 (es) | Compuestos derivados de 2-amino-4-bicicloamino-1,3,5-triazinas; composicion herbicida que los contiene; procedimiento de preparacion; uso de dichos compuestos; y compuestos intermediarios. | |
ES2114487B1 (es) | Mezcla estabilizante sinergistica. | |
PT1109812E (pt) | Pirrolobenzodiazepinas | |
PT960107E (pt) | Compostos de paclitaxel 6-tio-substituidos | |
DK0695171T3 (da) | Lyosfærer indeholdende gonadotropin | |
MX9804588A (es) | Uso de composiciones que comprenden blanqueador de halogeno para suavidad mejorada a la piel. | |
IT1293778B1 (it) | 1,4,7,10-tetraazabiciclo(8.2.2.)tetradecan-2 one, sua preparazione e suo uso per la preparazione di tetraazamacrocicli | |
MX9200731A (es) | Compuestos de hidrazona, procedimientos para su prcompuestos de hidrazona, procedimientos para su preparacion, compuestos intermedios utiles para su oeparacion, compuestos intermedios utiles para suobtencion y composiciones pesticidas que contienena btencion y composiciones pesticidas que contienenalos mismos. los mismos. | |
DK0842165T3 (da) | Thiazolidin-4-carboxylsyrederivater som cytobeskyttende midler | |
KR960703863A (ko) | 암 치료용 신규 비스-나프탈이미드(New Bis-naphthalimides for the Treatment of Cancer) | |
ES2105605T3 (es) | Antagonistas de taquiquinina, su preparacion y utilizacion en formulaciones farmaceuticas. | |
BR9814495A (pt) | Composto, processo para prepará-lo, uso do mesmo, composição farmacêutica, e, processo | |
MY127474A (en) | Naphthyl compounds, intermediates, compositions, and methods of use | |
AR008474A1 (es) | Derivado de 9-dihidroeritromicina a 6,9; 11,12-diciclocarbonato, composicion farmaceutica y preparacion bactericida que lo contienen y su uso | |
DK1073447T3 (da) | N1-modificerede glycopeptider | |
ES2179375T3 (es) | Composiciones farmaceuticas estabilizadas, a base de quinupristina y de dalfopristina y su preparacion. | |
NO923266D0 (no) | Heksahydrobenzo(f)quinolinoner | |
EA200000112A1 (ru) | Новая композиция | |
ES2175661T3 (es) | Derivados de la isoflavona, procedimientos para la preparacion de los mismos y composiciones farmaceuticas que los contienen. | |
MX9203732A (es) | R-enentiomeros de compuestos de n-propargil-1-aminoindan, su preparacion y composiciones farmaceuticas que contienen los mismos. | |
ATE282608T1 (de) | Chinoxalindionen | |
DE69614552T2 (de) | MODIFIZIERTE ALPHA-D-GLCP-(1,2)-ALPHA-D-Glcp-(1,3)-ALPHA-D-Glcp-ANALOGE | |
MX9202432A (es) | Compuestos de 4,5-dihidro-1,4-benzotiazepin-3(2h)onas, procedimiento para su preparacion y composiciones farmaceuticas que los contienen. | |
ES2116241B1 (es) | Composicion para la obtencion de un aguardiente. |